India Globalization Capital, Inc.(NYSE Amex Equities : IGC)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | 0.27% | 93.67 | 1.3% | $1008.13m | |
| BIIB | Biogen Inc. | 0.61% | 230.21 | 1.3% | $687.10m | |
| AMGN | Amgen Inc. | 1.93% | 179.76 | 1.3% | $470.05m | |
| GILD | Gilead Sciences, Inc. | 1.89% | 63.04 | 0.9% | $441.53m | |
| ILMN | Illumina, Inc. | 0.93% | 322.06 | 3.5% | $285.16m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 3.03% | 344.14 | 2.6% | $275.35m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 4.07% | 175.37 | 1.9% | $247.10m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 2.64% | 132.37 | 2.0% | $175.19m | |
| EXAS | Exact Sciences Corporation | 3.61% | 93.94 | 25.3% | $160.74m | |
| SRPT | Sarepta Therapeutics, Inc. | 3.78% | 118.09 | 14.7% | $144.55m | |
| A | Agilent Technologies, Inc. | -0.04% | 75.54 | 1.6% | $142.04m | |
| ONCE | Spark Therapeutics, Inc. | 0.00% | 110.60 | 11.2% | $133.55m | |
| INCY | Incyte Corporation | 2.38% | 75.41 | 2.5% | $98.69m | |
| IONS | Ionis Pharmaceuticals, Inc. | 3.25% | 75.00 | 8.3% | $95.31m | |
| BMRN | BioMarin Pharmaceutical Inc. | 2.74% | 86.00 | 4.3% | $93.68m |
Company Profile
India Globalization Capital, Inc. engages in the development and commercialization of cannabinoid based alternative therapies for indications such as Alzheimer's disease, Parkinson's disease, and pain. It operates through Legacy Infrastructure and Alternative Therapies segments. The Legacy Infrastructure segment involves in the trading of infrastructure commodities like steel and iron ore; and rental of heavy equipment. The Alternative Therapies segment focuses on the development and commercialization of cannabinoid-based combination therapies. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Bethesda, MD.